RUKOBIA
Identification of Rukobia
| No description |
Google image searchProduct monograph
Active ingredient
fostemsavir (fostemsavir tromethamine), 600 MG
DIN: 02520869
Dosage form(s): TABLET (EXTENDED-RELEASE)
Route(s) of administration: ORAL
Schedule: Prescription
Company: VIIV HEALTHCARE ULC
Date: 26-APR-2022
ATC:
- J05 — ANTIVIRALS FOR SYSTEMIC USE (ATC, ATC/DDD, )
- J05A — DIRECT ACTING ANTIVIRALS (ATC, ATC/DDD)
- J05AX — Other antivirals (ATC, ATC/DDD)
- J05AX29 — FOSTEMSAVIR (ATC/DDD)
Reference brand drug: Rukobia
